In this study, the levels of GM-CSF, IL-2, IL-12, and IL-1β were elevated, and the levels of TGF-β1 were reduced in the culture supernatants of in vitro stimulated PBMC from MS patients. The gene discussed is IL1B; the disease is myeloid sarcoma.